These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31257257)

  • 1. [Elucidation of the Molecular Basis of Abnormal Prion Protein (PrP) Formation in a Cell-Free System Using Baculovirus and Insect Cell-derived Recombinant PrP].
    Imamura M; Mori T; Takatsuki H; Iwamaru Y; Atarashi R
    Yakugaku Zasshi; 2019; 139(7):989-992. PubMed ID: 31257257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.
    Imamura M; Tabeta N; Kato N; Matsuura Y; Iwamaru Y; Yokoyama T; Murayama Y
    J Biol Chem; 2016 Dec; 291(51):26478-26486. PubMed ID: 27821590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins.
    Imamura M; Kato N; Okada H; Yoshioka M; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
    PLoS One; 2013; 8(12):e82538. PubMed ID: 24367521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.
    Imamura M; Kato N; Yoshioka M; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
    J Virol; 2011 Mar; 85(6):2582-8. PubMed ID: 21228241
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple affinity purification of a baculovirus-derived recombinant prion protein with in vitro ability to convert to its pathogenic form.
    Imamura M; Kato N; Iwamaru Y; Mohri S; Yokoyama T; Murayama Y
    Prep Biochem Biotechnol; 2017 Jan; 47(1):1-7. PubMed ID: 26918377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
    Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
    Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous generation of distinct prion variants with recombinant prion protein from a baculovirus-insect cell expression system.
    Imamura M; Tabeta N; Iwamaru Y; Takatsuki H; Mori T; Atarashi R
    Biochem Biophys Res Commun; 2022 Jul; 613():67-72. PubMed ID: 35537287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
    Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
    PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.
    Lawson VA; Lumicisi B; Welton J; Machalek D; Gouramanis K; Klemm HM; Stewart JD; Masters CL; Hoke DE; Collins SJ; Hill AF
    PLoS One; 2010 Aug; 5(8):e12351. PubMed ID: 20808809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a methodology for large-scale production of prions for biological and structural studies.
    Concha-Marambio L; Wang F; Armijo E; Gorski D; Ramirez F; Scowcroft A; Pritzkow S; Soto C
    Front Mol Biosci; 2023; 10():1184029. PubMed ID: 37635939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Prion Selection and Adaptation.
    Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
    Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the inhibitory potential of caffeic acid phenethyl ester on prion replication, amplification, and fibril formation
    Chao ZY; Jia XX; Zeng JF; Wu YZ; Xiao K; Gao LP; Shi Q; Dong XP; Chen C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jul; 58(7):1011-1019. PubMed ID: 39034785
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions.
    Gao C; Han J; Zhang J; Wei J; Zhang BY; Tian C; Zhang J; Shi Q; Dong XP
    Mol Neurobiol; 2017 Jul; 54(5):3771-3782. PubMed ID: 27259989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.